Literature DB >> 14760317

Prevalence of structural cardiac abnormalities in patients with myotonic dystrophy type I.

Deepak Bhakta1, Miriam R Lowe, William J Groh.   

Abstract

BACKGROUND: Myotonic dystrophy type 1 (DM1) is a neurological disorder with known cardiac involvement, including conduction disturbances, arrhythmias, and ventricular dysfunction. We studied which clinical and electrocardiographic features are associated with structural cardiac abnormalities.
METHODS: History, physical examination, electrocardiography, and genetic testing were performed on 382 patients with DM1, and cardiac imaging was performed on 100 of these patients.
RESULTS: Clinical congestive heart failure was found in 7 of the 382 patients (1.8%). Structural cardiac abnormalities determined with cardiac imaging included left ventricular hypertrophy (19.8%), left ventricular dilatation (18.6%), left ventricular systolic dysfunction (14.0%), mitral valve prolapse (13.7%), regional wall motion abnormality (11.2%), and left atrial dilatation (6.3%). Left ventricular systolic dysfunction was associated with increasing age (relative risk [RR], 1.9 per decade; 95% CI, 1.1-3.2; P =.02), cytosine-thymine-guanine (CTG) repeat length (RR, 2.8 per 500 repeats; 95% CI, 1.3-6.3; P =.01), P-R >200 ms (RR, 14.7; 95% CI, 3.0-73.1; P =.001), and QRS >120 ms (RR, 5.7; 95% CI, 1.5-21.8; P =.01). P-R >200 ms was predictive of regional wall motion abnormalities. QRS >120 ms correlated with regional wall motion abnormalities and left atrial dilatation.
CONCLUSIONS: Several clinical and electrocardiographic findings in patients with DM1 are significantly associated with structural heart abnormalities. These results suggest an underlying genetic and pathophysiologic correlate that may lead to cardiac disease in these patients.

Entities:  

Mesh:

Year:  2004        PMID: 14760317     DOI: 10.1016/j.ahj.2003.08.008

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  26 in total

1.  Non-invasive evaluation of the relationship between electrical and structural cardiac abnormalities in patients with myotonic dystrophy type 1.

Authors:  Lukas Chmielewski; Michael Bietenbeck; Alexandru Patrascu; Sabine Rösch; Udo Sechtem; Ali Yilmaz; Anca-Rezeda Florian
Journal:  Clin Res Cardiol       Date:  2019-02-14       Impact factor: 5.460

2.  Diastolic heart dysfunction is correlated with CTG repeat length in myotonic dystrophy type 1.

Authors:  Jin-Sung Park; Namkyun Kim; Donghwi Park
Journal:  Neurol Sci       Date:  2018-08-09       Impact factor: 3.307

3.  Aberrant Expression of a Non-muscle RBFOX2 Isoform Triggers Cardiac Conduction Defects in Myotonic Dystrophy.

Authors:  Chaitali Misra; Sushant Bangru; Feikai Lin; Kin Lam; Sara N Koenig; Ellen R Lubbers; Jamila Hedhli; Nathaniel P Murphy; Darren J Parker; Lawrence W Dobrucki; Thomas A Cooper; Emad Tajkhorshid; Peter J Mohler; Auinash Kalsotra
Journal:  Dev Cell       Date:  2020-02-27       Impact factor: 12.270

Review 4.  Mechanisms and management of the heart in myotonic dystrophy.

Authors:  Elizabeth M McNally; Dina Sparano
Journal:  Heart       Date:  2011-07       Impact factor: 5.994

5.  Assessment of cardiac involvement in myotonic muscular dystrophy by T1 mapping on magnetic resonance imaging.

Authors:  Evrim B Turkbey; Neville Gai; João A C Lima; Rob J van der Geest; Kathryn R Wagner; Gordon F Tomaselli; David A Bluemke; Saman Nazarian
Journal:  Heart Rhythm       Date:  2012-06-16       Impact factor: 6.343

Review 6.  Myotonic disorders and pregnancy.

Authors:  Adam Morton
Journal:  Obstet Med       Date:  2019-03-16

7.  Heart-specific overexpression of CUGBP1 reproduces functional and molecular abnormalities of myotonic dystrophy type 1.

Authors:  Misha Koshelev; Satyam Sarma; Roger E Price; Xander H T Wehrens; Thomas A Cooper
Journal:  Hum Mol Genet       Date:  2010-01-05       Impact factor: 6.150

8.  Usefulness of clinical and electrocardiographic data for predicting adverse cardiac events in patients with myotonic dystrophy.

Authors:  Robert Breton; Jean Mathieu
Journal:  Can J Cardiol       Date:  2009-02       Impact factor: 5.223

Review 9.  Myotonic Dystrophies: Targeting Therapies for Multisystem Disease.

Authors:  Samantha LoRusso; Benjamin Weiner; W David Arnold
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

10.  Non-ischemic cardiomyopathy attributed to adult myotonic dystrophy.

Authors:  Hyun Kyung Park; Won Hyeong Park; Dae-Geun Song; Tae Gyoon Kim; Bo Young Min; Keun Lee; Joong-Il Park
Journal:  Korean Circ J       Date:  2009-08-27       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.